Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05832983 · ClinicalTrials.gov registry record · NA

Aromatherapy and Anxiety Study

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT05832983 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05832983, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

While intra-articular injections can alleviate pain in orthopedic patients, this can be an anxiety-provoking experience. Adult patients scheduled to receive an injection at the study location will be randomly assigned to one of three groups. The control group (C) will receive the current standard of nursing care. The first experimental group (A) will receive a guided meditation prior to receiving the injection. The second experimental group (B) will receive an Elequil Aromatab and the same guided meditation prior to receiving the injection.

Interventions

  • BEHAVIORAL Guided Meditation
  • OTHER Aromatherapy

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2023-07-04
Est. Completion 2024-02-21
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT05832983

The ClinicalTrials.gov registry entry for NCT05832983 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Guided Meditation is the first listed.

NCT05832983 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05832983 about?

NCT05832983 is a clinical study titled "Aromatherapy and Anxiety Study". While intra-articular injections can alleviate pain in orthopedic patients, this can be an anxiety-provoking experience. Adult patients scheduled to receive an injection at the study location will be randomly assigned to one of three groups. The control group (C) will receive the current standard of...

What is the current status of trial NCT05832983?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2023-07-04. Estimated completion is 2024-02-21.

What interventions are being tested in trial NCT05832983?

The interventions under investigation include: Guided Meditation (BEHAVIORAL), Aromatherapy (OTHER).

Who is sponsoring clinical trial NCT05832983?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.